BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 176457)

  • 1. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
    Summers WC; Klein G
    J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid.
    Yajima Y; Tanaka A; Nonoyama M
    Virology; 1976 May; 71(1):352-4. PubMed ID: 179207
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production.
    Nyormoi O; Thorley-Lawson DA; Elkington J; Strominger JL
    Proc Natl Acad Sci U S A; 1976 May; 73(5):1745-8. PubMed ID: 179098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Epstein-Barr virus DNA in vitro: effects of phosphonoacetic acid, N-ethylmaleimide, and ATP.
    Seebeck T; Shaw JE; Pagano JS
    J Virol; 1977 Jan; 21(1):435-8. PubMed ID: 189079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    Yajima Y; Nonoyama M
    J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
    Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
    Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of phosphonoacetic acid on early antigen synthesis in two Epstein-Barr virus producer cell lines.
    Patel P; Menezes J
    Virology; 1979 Jan; 92(1):236-9. PubMed ID: 217163
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
    Flamand L; Stefanescu I; Ablashi DV; Menezes J
    J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition by phosphonoacetic acid of MDV DNA replication in a lymphoblastoid cell line.
    Nazerian K; Lee LF
    Virology; 1976 Oct; 74(1):188-93. PubMed ID: 185787
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis.
    Feighny RJ; Henry BE; Pagano JS
    J Virol; 1981 Jan; 37(1):61-71. PubMed ID: 6261001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid.
    Thorley-Lawson D; Strominger JL
    Nature; 1976 Sep; 263(5575):332-4. PubMed ID: 183149
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
    Margalith M; Manor D; Usieli V; Goldblum N
    Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of Epstein-Barr virus early antigen, virus capsid antigen and virus DNA synthesis by mitomycin C.
    Ernberg I; Moar MH
    J Gen Virol; 1981 Jan; 52(Pt 1):39-48. PubMed ID: 6267175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
    Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence of Epstein-Barr virus productive cycle in human lymphoblastoid cells.
    Hampar B; Derge JG; Tanaka A; Nonoyama M
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():811-5. PubMed ID: 169035
    [No Abstract]   [Full Text] [Related]  

  • 16. The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.
    Decaussin G; Leclerc V; Ooka T
    J Virol; 1995 Nov; 69(11):7309-14. PubMed ID: 7474160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response.
    Casareale D; Jones W; Sairenji T; Humphreys RE
    Infect Immun; 1983 Jan; 39(1):85-90. PubMed ID: 6295961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro.
    Lin JC
    Antiviral Res; 2003 Jun; 59(1):41-7. PubMed ID: 12834859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus. IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid.
    Huang ES
    J Virol; 1975 Dec; 16(6):1560-5. PubMed ID: 172657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.